Gujarat Terce Laboratories Limited (BOM:524314)
India · Delayed Price · Currency is INR 46.30
-0.37 (-0.79%)
At close: Nov 6, 2026
BOM:524314 Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 459.11 | 474.73 | 501.95 | 479.75 | 467.83 | 401.34 | |
Revenue Growth | -6.18% | -5.42% | 4.63% | 2.55% | 16.57% | 59.40% |
Cost of Revenue | 160.47 | 174.1 | 192.21 | 177.53 | 193.8 | 154.49 |
Gross Profit | 298.64 | 300.63 | 309.74 | 302.22 | 274.02 | 246.85 |
Selling, General & Admin | 185.34 | 184.57 | 195.01 | 190.32 | 175.62 | 182.22 |
Other Operating Expenses | 78.49 | 78.57 | 75.9 | 99.23 | 120 | 53.45 |
Operating Expenses | 268.25 | 267.37 | 274.76 | 293.23 | 299.26 | 238.43 |
Operating Income | 30.4 | 33.25 | 34.98 | 8.99 | -25.24 | 8.42 |
Interest Expense | -1.12 | -1.57 | -3.62 | -6.28 | -6.68 | -3.33 |
Interest & Investment Income | 1.67 | 1.67 | 2.56 | 3.03 | 3.55 | 2.88 |
Other Non Operating Income (Expenses) | 0.85 | 0.85 | -0.13 | -0.3 | -0.53 | -0.68 |
EBT Excluding Unusual Items | 31.8 | 34.21 | 33.79 | 5.44 | -28.9 | 7.28 |
Gain (Loss) on Sale of Investments | 0.56 | 0.56 | 0.11 | - | - | - |
Gain (Loss) on Sale of Assets | 0.03 | 0.03 | - | - | -0.04 | - |
Other Unusual Items | -4.54 | -4.54 | - | - | - | - |
Pretax Income | 27.91 | 30.32 | 33.91 | 5.44 | -28.94 | 7.47 |
Income Tax Expense | 8.09 | 8.31 | 43.69 | 3.01 | -12.22 | -1.26 |
Net Income | 19.83 | 22.02 | -9.79 | 2.44 | -16.72 | 8.72 |
Net Income to Common | 19.83 | 22.02 | -9.79 | 2.44 | -16.72 | 8.72 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 8 | 8 | 7 | 7 | 7 | 7 |
Shares Outstanding (Diluted) | 8 | 8 | 7 | 7 | 7 | 7 |
Shares Change | 4.03% | 1.45% | - | - | - | - |
EPS (Basic) | 2.57 | 2.92 | -1.32 | 0.33 | -2.25 | 1.18 |
EPS (Diluted) | 2.56 | 2.92 | -1.32 | 0.33 | -2.25 | 1.18 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | - | 16.84 | 30.59 | 25.26 | -0.36 | -25.57 |
Free Cash Flow Per Share | - | 2.24 | 4.12 | 3.40 | -0.05 | -3.45 |
Gross Margin | 65.05% | 63.33% | 61.71% | 63.00% | 58.57% | 61.51% |
Operating Margin | 6.62% | 7.00% | 6.97% | 1.87% | -5.39% | 2.10% |
Profit Margin | 4.32% | 4.64% | -1.95% | 0.51% | -3.57% | 2.17% |
Free Cash Flow Margin | - | 3.55% | 6.09% | 5.27% | -0.08% | -6.37% |
EBITDA | 34.82 | 37.48 | 38.83 | 12.67 | -21.59 | 11.18 |
EBITDA Margin | 7.58% | 7.90% | 7.74% | 2.64% | -4.61% | 2.78% |
D&A For EBITDA | 4.42 | 4.23 | 3.85 | 3.68 | 3.65 | 2.76 |
EBIT | 30.4 | 33.25 | 34.98 | 8.99 | -25.24 | 8.42 |
EBIT Margin | 6.62% | 7.00% | 6.97% | 1.87% | -5.39% | 2.10% |
Effective Tax Rate | 28.97% | 27.39% | 128.86% | 55.24% | - | - |
Revenue as Reported | 462.51 | 478.13 | 505.03 | 482.96 | 471.37 | 404.4 |
Advertising Expenses | - | 21.92 | 31.18 | 30.1 | 25.85 | 21.85 |